浙江东方：子公司发起设基金 控股股东提供借款额度

Group 1 - The company announced the establishment of the "Oriental Zhejiang Medicine Zhongying Binjiang Pharmaceutical Fuyou Fund" with a fundraising target of up to 500 million yuan [1] - The company’s wholly-owned subsidiary, Oriental Chanin, will contribute 121.2 million yuan, accounting for 24.04% of the fund, while Zhejiang Medicine Group will contribute 29.8 million yuan, accounting for 5.96% [1] - The company approved a loan limit of 1.3 billion yuan from the controlling shareholder to its subsidiary Guojin Financial Leasing for daily operations and debt replacement, with a maximum interest rate of 3.15% and a term not exceeding 3 years [1]